IPATF News and Press, ImmunoPrecise Antibodies Ltd. From 08/13/20

IPA Appoints New York Based Crescendo Communications as Investor Relations and Corporate Communications Advisor Canada NewsWire VICTORIA, BC, Aug. 13, 2020 VICTORIA, BC , Aug. 13, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) ...

VICTORIA, BC , July 31, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE:TQB2), a provider of best-in-class therapeutic antibody capabilities, is pleased to announce that additional characterization of a subset of fully human,...

IPA Awarded US$1.5M Bioscience Innovation Grant for Coronavirus Research from the North Dakota Department of Agriculture Canada NewsWire VICTORIA, BC, July 28, 2020 VICTORIA, BC , July 28, 2020 /CNW/ -IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTC...

IPA Announces Repayment of Remaining 2018 Debentures and $3,811,205 in Warrant Exercises Canada NewsWire VICTORIA, BC, July 20, 2020 VICTORIA, BC , July 20, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSX VENTURE: IPA) (OTCQB: IPATF) (FSE: TQ...

ImmunoPrecise Antibodies ( OTCQB:IPATF +6.5% ) identifies additional , human lead candidate antibodies against SARS-CoV-2, also demonstrating potent in vitro neutralizing activity. More news on: ImmunoPrecise Antibodies Ltd., Ligand Pharmaceuticals Incorporated, Healthcare stocks news, ...

IPA announces discovery of additional, neutralizing antibodies, developed against SARS-CoV-2, discovered using Ligand Pharmaceuticals' genetically engineered OmniRat® strains producing human antibodies VICTORIA , July 13, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES L...

ImmunoPrecise Antibodies ( OTCQB:IPATF +6.9% ) announces identification of numerous lead candidate antibodies with highly-potent neutralizing activity in vitro. More news on: ImmunoPrecise Antibodies Ltd., Healthcare stocks news, Read more ...

IPA Announces  Discovery of Functional Antibodies from Humans and Llama (VHH), Identified Using IPA Phage Display Technology VICTORIA, BC , June 29, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), an exp...

Collaborative COVID-19 Vaccine Project Between ImmunoPrecise Antibodies Europe and LiteVax BV, Funded Through TRANSVAC2 Canada NewsWire OSS, Netherlands, June 22, 2020 OSS, Netherlands , June 22, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TS...

ImmunoPrecise Antibodies ( OTCQB:IPATF -3.4% ) subsidiary U-Protein Express BV announces the availability of new recombinant SARS-CoV-2 proteins, along with other COVID-19-associated proteins, for research use in the design and discovery of diagnostic tests, therapeutics and vaccines for...